Abstract:Dysfunctional immune cells participate in the pathogenesis of a variety of autoimmune diseases, although the specific mechanisms remain elusive and effective clinical interventions are lacking. Recent research on immune checkpoint molecules has revealed significant expression of T cell immunoglobulin and mucin domain-containing protein 3 (TIM-3) on the surfaces of various immune cells. These include different subsets of T cells, macrophages, dendritic cells, natural killer cells, and mast cells. Further investigation into its protein structure, ligands, and intracellular signaling pathway activation mechanisms has found that TIM-3, by binding with different ligands, is involved in the regulation of crucial biological processes such as proliferation, apoptosis, phenotypic transformation, effector protein synthesis, and cellular interactions of various immune cells. The TIM-3-ligand axis plays a pivotal role in the pathogenesis of numerous conditions, including autoimmune diseases, infections, cancers, transplant rejection, and chronic inflammation. This article primarily focuses on the research findings of TIM-3 in the field of autoimmune diseases, with a special emphasis on the structure and signaling pathways of TIM-3, its types of ligands, and the potential mechanisms implicated in systemic lupus erythematosus, multiple sclerosis, rheumatoid arthritis, as well as other autoimmune diseases and chronic inflammation. The latest research results in the field of immunology suggest that TIM-3 dysfunction affects various immune cells and participates in the pathogenesis of diseases. Monitoring the activity of its receptor-ligand axis can serve as a novel biological marker for disease clinical diagnosis and prognosis evaluation. More importantly, the TIM-3-ligand axis and the downstream signaling pathway molecules may become key targets for targeted intervention treatment of autoimmune-related diseases.

Tim-3 Relieves Experimental Autoimmune Encephalomyelitis by Suppressing MHC-II

Tim-3 Promotes <i>Listeria monocytogenes</i> Immune Evasion by Suppressing Major Histocompatibility Complex Class I

Tim-3 Inhibits Macrophage Control of Listeria Monocytogenes by Inhibiting Nrf2

Ubiquitination and degradation of MHC-II by Tim-3 inhibits antiviral immunity

T-cell immunoglobulin and mucin-domain containing-3 (TIM-3): Solving a key puzzle in autoimmune diseases

Tim-3: An Activation Marker and Activation Limiter of Innate Immune Cells

TIM-3, a Promising Target for Cancer Immunotherapy

Monoclonal antibody against human Tim-3 enhances antiviral immune response

Tim-3-Expressing Cd4(+) And Cd8(+) T Cells In Human Tuberculosis (Tb) Exhibit Polarized Effector Memory Phenotypes And Stronger Anti-Tb Effector Functions

Tim-3 promotes viral infection by suppressing USP25-TRAF3-IRF7 signaling pathway

Tim-3 adapter protein Bat3 acts as an endogenous regulator of tolerogenic dendritic cell function

Expression of Tim-3 drives phenotypic and functional changes in Treg cells in secondary lymphoid organs and the tumor microenvironment

Intravenous Tolerance Modulates Macrophage Classical Activation and Antigen Presentation in Experimental Autoimmune Encephalomyelitis

Novel Roles of the Tim Family in Immune Regulation and Autoimmune Diseases

T Cell Immunoglobulin-3 As a New Therapeutic Target for Rheumatoid Arthritis

Tim-3 promotes tumor-promoting M2 macrophage polarization by binding to STAT1 and suppressing the STAT1-miR-155 signaling axis.

Tim-3 Promotes Intestinal Homeostasis in DSS Colitis by Inhibiting M1 Polarization of Macrophages

Tim-3 is dispensable for allergic inflammation and respiratory tolerance in experimental asthma

TIM-3 As a Target for Cancer Immunotherapy and Mechanisms of Action.

The TIM gene family regulates autoimmune and allergic diseases

MHC class II regulation of CD8+T cell tolerance and implications in autoimmunity and cancer immunotherapy